Interrater Reliability of the Modified Monitoring of Side Effects Scale for Assessment of Adverse Effects of Psychiatric Medication in Clinical and Research Settings

被引：7

作者：

Nugent, Katie L. ^{[1
]}

Spahr, Erin ^{[2
]}

Toroney, Jaimie ^{[3
]}

Mojtabai, Ramin ^{[4
]}

Nettles, Carrie ^{[5
]}

Turner, Lydia W. ^{[6
]}

Fenton, Ashley ^{[7
]}

Spivak, Amethyst ^{[8
]}

Cullen, Bernadette A. ^{[4
,9
]}

Everett, Anita ^{[2
]}

Eaton, William W. ^{[4
]}

机构：

[1] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Dept Psychiat, Baltimore, MD 21228 USA

[2] Johns Hopkins Bayview Med Ctr, Community Gen Psychiat Div, Baltimore, MD USA

[3] Kennedy Krieger Inst, Dept Internal Med, Baltimore, MD USA

[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA

[5] Kennedy Krieger Inst, Lab Neurocognit Imaging Res, Baltimore, MD USA

[6] Lewin Grp, Falls Church, VA USA

[7] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA

[8] Univ Maryland, Francis King Carey Sch Law, Baltimore, MD 21228 USA

[9] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2015年 / 35卷 / 03期

关键词：

adverse effects; psychiatric medications; rating scales; RATING-SCALE; SCHIZOPHRENIA; PREDICTORS; ADHERENCE;

D O I：

10.1097/JCP.0000000000000311

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The assessment of adverse effects of psychiatric medications is important in clinical and research settings because they are often associated with medication discontinuation, symptom exacerbation, and reduced quality of life. Currently available assessment tools are either limited with regard to the number and variety of included adverse effects or are not practical for use in most clinical or research settings owing to specialized rater training required and administration length. This report describes a modification of the Monitoring of Side Effects Scale (MOSES), an established adverse effect rating scale, by adding severity anchors to improve its reliability and ease of use. Interrater reliability was good for 7 of the 8 bodily adverse effects assessed, with intraclass correlation coefficients ranging from 0.76 to 0.91 in a sample of patients with severe mental illness. This modified version of the Monitoring of Side Effects Scale holds promise as a useful tool for assessing medication adverse effects in clinical and research settings.

引用

页码：324 / 328

页数：5

共 25 条

[21] ROSNER B, 2015, FUNDAMENTALS BIOSTAT
[22] SIMPSON GM, 1970, ACTA PSYCHIAT SCAND, P11
[23] Poor antipsychotic adherence among patients with schizophrenia: Medication and patient factors
Valenstein, M
Blow, FC
Copeland, LA
McCarthy, JF
Zeber, JE
Gillon, L
Bingham, CR
Stavenger, T
[J]. SCHIZOPHRENIA BULLETIN, 2004, 30 (02) : 255 - 264
[24] Weiden P., 1999, European Neuropsychopharmacology, V9, P266
[25] Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration
Yusufi, Babur
Mukherjee, Sujoy
Flanagan, Robert
Paton, Carol
Dunn, Graham
Page, Eleanor
Barnes, Thomas R. E.
[J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (04) : 238 - 243

← 1 2 3 →